NM_001101669.3:c.2146G>A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001101669.3(INPP4B):c.2146G>A(p.Val716Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000193 in 1,609,730 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001101669.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152058Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000405 AC: 1AN: 246902 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1457672Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 724986 show subpopulations
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152058Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74248 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2146G>A (p.V716M) alteration is located in exon 23 (coding exon 19) of the INPP4B gene. This alteration results from a G to A substitution at nucleotide position 2146, causing the valine (V) at amino acid position 716 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at